Utilization of the microbiome in personalized medicine

K Ratiner, D Ciocan, SK Abdeen, E Elinav - Nature Reviews …, 2024 - nature.com
Inter-individual human variability, driven by various genetic and environmental factors,
complicates the ability to develop effective population-based early disease detection …

The gut microbiome in disorders of gut–brain interaction

N Kraimi, T Ross, J Pujo, G De Palma - Gut Microbes, 2024 - Taylor & Francis
Functional gastrointestinal disorders (FGIDs), chronic disorders characterized by either
abdominal pain, altered intestinal motility, or their combination, have a worldwide …

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

M Camilleri, G Boeckxstaens - Gut, 2023 - gut.bmj.com
Objective To appraise the evidence that pathophysiological mechanisms and individualised
treatment directed at those mechanisms provide an alternative approach to the treatment of …

Lactiplantibacillus plantarum P9 for chronic diarrhea in young adults: a large double-blind, randomized, placebo-controlled trial

N Yang, T Ma, Y Xie, Q Li, Y Li, L Zheng, Y Li… - Nature …, 2024 - nature.com
Current treatments for chronic diarrhea have limited efficacy and several side effects.
Probiotics have the potential to alleviate symptoms of diarrhea. This randomized, double …

The Role of the FODMAP Diet in IBS

L Bertin, M Zanconato, M Crepaldi, G Marasco… - Nutrients, 2024 - mdpi.com
The low FODMAP (fermentable oligosaccharide, disaccharide, monosaccharide, and polyol)
diet is a beneficial therapeutic approach for patients with irritable bowel syndrome (IBS) …

Celiac disease–related conditions: who to test?

F Zingone, JC Bai, C Cellier, JF Ludvigsson - Gastroenterology, 2024 - Elsevier
Celiac disease (CeD) is a chronic immune-mediated condition triggered by gluten
consumption in genetically predisposed individuals. Approximately 1% of the general …

Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria

G Konstantis, S Efstathiou, C Pourzitaki, E Kitsikidou… - Clinical Nutrition, 2023 - Elsevier
Summary Background Irritable Bowel Syndrome (IBS) is a functional gastrointestinal
disorder which affects a great number of patients globally. Clinical trials and meta-analyses …

Myths and facts about food intolerance: a narrative review

F Zingone, L Bertin, D Maniero, M Palo, G Lorenzon… - Nutrients, 2023 - mdpi.com
Most adverse reactions to food are patient self-reported and not based on validated tests but
nevertheless lead to dietary restrictions, with patients believing that these restrictions will …

Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial

C Borup, L Vinter-Jensen, SPG Jørgensen… - The Lancet …, 2023 - thelancet.com
Background Bile acid diarrhoea is a common but overlooked cause of chronic watery
diarrhoea. Plasma 7α-hydroxy-4-cholesten-3-one (C4) is an alternative to the gold standard …

Nutrition and Disorders of Gut–Brain Interaction

E Scarpellini, LM Balsiger, B Broeders, KVD Houte… - Nutrients, 2024 - mdpi.com
Background: Disorders of gut–brain interaction (DGBIs) have a complex pathophysiology
that is often characterized by a relationship between food ingestion and triggering of …